I have received a number of e-mails from men who are both frustrated that Provenge is not yet approved and who are frustrated that even when approved they will not qualify to get the treatment. I understand the frustration and feel the same way. The first question is will the FDA approve Provenge? Only time [...]
I have just read a report from Mike Scott of a 64-year-old Croatian man who was recently diagnosed with advanced prostate cancer. His PSA was 21,380 ng/ml! Yes, I said a PSA of 21,380. Now, hold on to your seats for even more intriguing information. According to the report this man has never experienced any [...]
The following was sent to me as a comment to a prior post. Instead, I think the comment warrants being put up as its own separate post. It is written by a urologist who has requested that I only use his initials instead of his full name. I would like to thank you for your [...]
Roche Pharmaceuticals has reported that their clinical trial of Avastin in men with advanced prostate cancer did not improve their overall life expectancy. […]
Watson Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Trelstar – 22.5 mg (triptorelin pamoate for injectable suspension) at a dosage which will be required only to be administered twice a year. […]
Sen. John McCain’s (R- Arizona) office has confirmed that the Senator no longer supports his own bill that would significantly tighten the regulatory requirements for dietary supplements. Currently, the manufacturing of supplements is not monitored or controlled by any governmental agency. There is no way to know that the supplement you purchase contains what is [...]
The drug is called Cabazitaxel, (it will be named Jevtana) and is made by the French company Sanofi-Aventis SA. Cabazitaxel is a chemical cousin of Taxotere (the current standard of care) and it is designed to evade the mechanism that cancer cells use to resist Taxotere, so we can assume that initially it would be [...]
The House Committee on Oversight and Government Reform, chaired by Congressman Edolphus Towns, will hold a hearing entitled: “Prostate Cancer: New Questions About Screening and Treatment” tomorrow, Thursday, March 4, 2010 at 10:00 a.m. This is the first Congressional prostate cancer hearing in 11 years and, in the midst of debate on a health reform [...]
According to a Reuters report, a spokeswomen from the FDA said yesterday that, “There is not going to be an additional advisory committee meeting” about the current application for the approval of Provenge. The FDA has the right to convene another meeting to discuss the results of the IMPACT trial, but it now looks as [...]
We have had fish oil on our must consume list for many years, now there might be some additional data confirming this long known recommendation. Research published in the March 2010 print edition of the FASEB Journal reports that scientists have show that the omega-3 fatty acid, “docosahexaenoic acid” or “DHA,” and its derivatives in [...]
